Brunet-Maheu Jean-Marc, Fernandes Julio C, de Lacerda Clemente A V, Shi Qin, Benderdour Mohamed, Lavigne Patrick
Orthopaedic Research Laboratory, Department of Orthopaedics, Centre hospitalier Sacré-Coeur, Montréal, Québec, Canada.
J Biomater Appl. 2009 Sep;24(3):275-87. doi: 10.1177/0885328208096534. Epub 2008 Nov 5.
The objective of this study is to report the effect of Pluronic F-127 on osteoblast viability and phenotype maintenance in vitro. MG-63 cells are suspended in Pluronic F-127, and MTT assay, alkaline phosphatase activity, prostaglandin E(2) production, collagen-I, and cyclo-oxygenase-2 expression are assessed up to 6 days. Pluronic F-127 leads to a significant decrease in osteoblast viability throughout the 6-day experiment, without altering osteoblast phenotype. The addition of platelet-rich plasma to the polymer/cell construct leads to increased cell survival. When supplemented with bioactive factors, Pluronic F-127 could potentially be used as a cell carrier in bone tissue engineering.
本研究的目的是报告普朗尼克F-127对体外成骨细胞活力和表型维持的影响。将MG-63细胞悬浮于普朗尼克F-127中,进行MTT试验、碱性磷酸酶活性、前列腺素E(2)生成、I型胶原蛋白和环氧化酶-2表达的评估,最长持续6天。在整个6天的实验中,普朗尼克F-127导致成骨细胞活力显著下降,但不改变成骨细胞表型。向聚合物/细胞构建体中添加富血小板血浆可提高细胞存活率。当补充生物活性因子时,普朗尼克F-127有可能用作骨组织工程中的细胞载体。